Linyan Zhu Selected Research

Linyan Zhu Research Topics

Disease

24	Nasopharyngeal Carcinoma 12/2019 - 10/2002
15	Neoplasms (Cancer) 04/2024 - 06/2010
5	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2015
4	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2016
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 12/2017
2	Pheochromocytoma 08/2013 - 10/2009
1	Quadriplegia (Spastic Quadriplegia) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2023
1	Microcephaly 01/2023
1	Muscular Dystrophies (Muscular Dystrophy) 01/2023
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 04/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Starvation 01/2019
1	Adenocarcinoma of Lung 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Alcoholism (Alcohol Abuse) 11/2016
1	Carcinoma (Carcinomatosis) 02/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 09/2010

Drug/Important Bio-Agent (IBA)

24	Chloride Channels (Chloride Channel)IBA 01/2023 - 10/2009
12	ChloridesIBA 04/2022 - 10/2002
9	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2013
3	Estrogen ReceptorsIBA 01/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	disulfiram-copperIBA 04/2022 - 12/2019
2	Tamoxifen FDA LinkGeneric 02/2020 - 02/2018
2	Long Noncoding RNAIBA 04/2018 - 01/2018
2	Disulfiram (Antabuse)FDA Link 01/2017 - 11/2016
2	Aquaporins (Water Channels)IBA 03/2016 - 12/2014
2	Cyclin D1IBA 01/2016 - 03/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2013 - 10/2009
2	Adenosine Triphosphate (ATP)IBA 02/2012 - 10/2011
1	Carbon Nanotubes (Carbon Nanotube)IBA 04/2024
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2023
1	Laminin (Merosin)IBA 01/2023
1	PlatinumIBA 01/2023
1	AndrogensIBA 04/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2022
1	TubulinIBA 06/2021
1	Cytoskeletal ProteinsIBA 02/2020
1	Estrogen Receptor alphaIBA 02/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	SolventsIBA 12/2019
1	artenimol (dihydroartemisinin)IBA 11/2018
1	Diphosphonates (Bisphosphonates)IBA 10/2018
1	Zoledronic Acid (Zometa)FDA Link 10/2018
1	Estrogens (Estrogen)FDA Link 02/2018
1	Estrogen Receptor Modulators (Antiestrogen)IBA 02/2018
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Antisense RNA (Anti-Sense RNA)IBA 01/2018
1	K-80003IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 12/2017
1	Cadherins (E-Cadherin)IBA 12/2017
1	Emodin (Archin)IBA 06/2017
1	BromidesIBA 06/2017
1	CopperIBA 11/2016
1	AquaglyceroporinsIBA 03/2016
1	Glycerol (Glycerine)FDA LinkGeneric 03/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Ethanol (Ethyl Alcohol)IBA 08/2015
1	Purinergic Receptors (Receptors, Purine)IBA 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	AcidsIBA 07/2012
1	Tumor Biomarkers (Tumor Markers)IBA 02/2012
1	Excipients (Suspending Agents)IBA 09/2010
1	LithiumIBA 09/2010
1	Lithium ChlorideIBA 09/2010
1	SaltsIBA 09/2010
1	SolutionsIBA 10/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2023
1	Therapeutics 04/2022
1	Immunotherapy 01/2019
1	Lasers (Laser) 11/2016
1	Chemoradiotherapy 02/2015
1	Microelectrodes 08/2012